Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting
ContributorsAlbrich, Werner C; Harbarth, Stéphan Juergen
Published inIntensive care medicine, vol. 41, no. 10, p. 1739-1751
Publication date2015
Abstract
Affiliation entities
Research groups
Citation (ISO format)
ALBRICH, Werner C, HARBARTH, Stéphan Juergen. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting. In: Intensive care medicine, 2015, vol. 41, n° 10, p. 1739–1751. doi: 10.1007/s00134-015-3978-8
Main files (1)
Article (Published version)
Identifiers
- PID : unige:77979
- DOI : 10.1007/s00134-015-3978-8
- PMID : 26194026
Journal ISSN0342-4642
